Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 BuSpar (Buspirone Hydrochloride) Capsules
Company:  Bristol-Myers Squibb Co.
Application No.:  021190
Approval Date: 12/20/2000


Date created: March 112004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.